
Umbralisib-Induced Immune-Mediated Colitis: A Concerning Adverse Effect of the Novel PI3Kδ/CK1ε Inhibitor
Author(s) -
Suryansh Bajaj,
Stevi Barrett,
Raouf E. Nakhleh,
Bhaumik Brahmbhatt,
Yan Bi
Publication year - 2021
Publication title -
acg case reports journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 4
ISSN - 2326-3253
DOI - 10.14309/crj.0000000000000701
Subject(s) - medicine , adverse effect , colitis , immune system , clinical trial , pharmacology , immunology , toxicity , oncology